Liminal BioSciences Inc (LMNL) stock is lower by -30.63% over the last 12 months, and the average rating from Wall Street analysts is a Strong Sell. InvestorsObserver’s proprietary ranking system, gives LMNL stock a score of 0 out of a possible 100. That rank is chiefly influenced by a short-term technical score of 0. LMN
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
